IP Litigation > Nova Content
CASE OF THE WEEK
Dana-Farber Cancer Institute, Inc. v. Ono Pharmaceutical Co., Ltd., Appeal No. 2019-2050 (Fed. Cir. July 14, 2020)
In this week’s Case... Read More »
Roughly 10% of AIA Proceedings Involve Amendments
Earlier this week the Patent Trial & Appeal Board (PTAB) released the sixth installment of its Motion to... Read More »
CASE OF THE WEEK
Uniloc 2017 LLC v. Apple, Inc., Appeal Nos. 2019-1922, -1923, -1925, -1926 (Fed. Cir. July 9, 2020)
This week’s case of the week... Read More »
CASE OF THE WEEK
Immunex Corp. v. Sandoz Inc., Appeal No. 2020-1037 (Fed. Cir. July 1, 2020)
In this Biologics Price Competition and Innovation Act case, the... Read More »
House and Senate Judiciary Committees Alerted to “Significant and Rapidly Growing Problem”
Earlier this month, a coalition of stakeholder... Read More »
CASE OF THE WEEK
adidas AG v. Nike, Inc., Appeal Nos. 2019-1787, -1788 (Fed. Cir. June 25, 2020)
This week’s case of the week deals with issues relating ... Read More »
Board Acknowledges Slipping WDTX Trial Date
Some weeks back I highlighted the institution decision in Sand Revolution II LLC., v. Continental Inter Modal Group... Read More »
CASE OF THE WEEK
Munchkin, Inc. v. Luv N’ Care, Ltd., Appeal No. 2019-1454 (Fed. Cir. June 8, 2020)
In its only precedential patent opinion issued this... Read More »
CASE OF THE WEEK
Amneal Pharmaceuticals LLC v. Almirall, LLC, Appeal No. 2020-1106 (Fed. Cir. June 4, 2020)
In the Federal Circuit’s only precedential... Read More »
CASE OF THE WEEK
ESIP Series 2, LLC v. Puzhen Life USA, LLC, Appeal No. 2019-1659 (Fed. Cir. May 19, 2020)
In this week’s Case of the Week, the Federal... Read More »
ESIP SERIES 2, LLC V. PUZHEN LIFE USA, LLC
Before Reyna, Lourie, and Hughes. Appeal from the Patent Trial and Appeal Board.
Summary: The PTAB’s... Read More »
PTAB Appeals Focused on Merits
The SCOTUS re-calibrated the PTAB’s appeal bar in Thryv, Inc v. Click-To-Call Techs., LP., explaining that potential... Read More »
Running a profitable patent prosecution practice has become more challenging in recent years. The recession triggered by the current pandemic is going to make this... Read More »
LEAP Program Launches 5/15
Today, the USPTO officially launched the Patent Trial and Appeal Board’s (PTAB) Legal Experience and Advancement Program (LEAP)... Read More »
A few weeks ago, for the first time, we compared the cost of patent prosecution for Apple’s top firms (Patexia Insight 77). One of our readers asked if we could ... Read More »
Public Policy Role of PTAB Clashes with Assignor Estoppel Equities
The doctrine of assignor estoppel prevents prior owners/inventors of a patent from later... Read More »
SCOTUS Clarifies PTAB Institution Issues Not Subject to Appeal
Back In December I pointed out that the SCOTUS would likely tighten the PTAB appeal bar in Dex... Read More »
Additional Briefing Invited on Binary Application of NHK
Last week I pointed out that the litigation timing factor introduced by NHK Spring Co. Ltd. v. Intri-Plex ... Read More »
GOLDEN v. U.S.
Before O’Malley, Mayer, and Wallach. Appeal from the United States Court of Federal Claims.
Summary: (1) Patent infringement claims ... Read More »
Cert Petitions Pursue Takings Clause Argument
Last week, Arthrex filed a petition for certiorari challenging the holding of the Federal Circuit that its... Read More »